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ABSTRACT: Porphobilinogen synthase catalyzes the first committed step of the tetrapyrrole biosynthesis pathway. In 
an aldol-like condensation, two molecules of 5-aminolevulinic acid (ALA) form the first pyrrole, porphobilinogen. 
Newly synthesized analogues of a reaction intermediate of porphobilinogen synthase have been employed in 
studying the active site and the catalytic mechanism of this early enzyme of tetrapyrrole biosynthesis. This study 
combines structural and kinetic evaluation of the inhibition potency of these inhibitors. In addition, one of the determined 
protein structures provides for the first time structural evidence of a magnesium ion in the active site. From these results, 
we can corroborate an earlier postulated enzymatic mechanism that starts with formation of a C-C bond, linking C3 of 
the A-side ALA to C4 of the P-side ALA through an aldole addition. The obtained data are discussed with respect 
to the current literature.
Porphobilinogen synthase (PBGS,1 EC 4.2.1.24), also
called 5-aminolevulinic acid dehydratase (ALAD), catalyzes
the first common step during the biosynthesis of tetrapyrroles
such as hemes, chlorophylls, and bilins (1, 2). During the
catalytic process, the asymmetric condensation of two
molecules of 5-aminolevulinic acid (ALA) yields the first
pyrrole porphobilinogen (PBG) (Figure 1). PBGSs from a
wide variety of organisms have been studied in detail, and
crystal structures of many have been published (3-7). The
most common active form of PBGS is a homo-octamer, but
it has been shown that lower oligomeric states can be
catalytically active as well (8). Each monomer consists of a
classical eight-stranded (âR)8 barrel with the active site
located at the C-terminal ends of the â-strands. A flexible
loop (lid) covers the active site and separates it from the
surrounding medium. The two ALA substrate molecules are
distinguished as A- and P-side ALA due to the acetic acid
and propanoic acid side chains, respectively, that they
contribute to the product PBG. The corresponding binding
sites of PBGS are termed the A-site and P-site, respectively.
Although it is a family of highly homologous enzymes,
significant variation can be observed in the employment of
metal ions at catalytic and allosteric sites. The PBGS from
Pseudomonas aeruginosa (PaPBGS) contains four magne-
sium ions per octamer which are located at an allosteric site
remote from the active site. Furthermore, monovalent cations
have been found in the active site and also at the subunit
interfaces (9, 10). PBGSs from other organisms have been
shown to contain zinc ions in the active site. Because of the
variable requirement for metal ions, a phylogenetic diversity
in the chemical reaction mechanism has been postulated
depending on whether the enzyme carries an active site zinc
ion (11). Despite the differences in metal ion utilization in
the enzyme family, it is commonly accepted that the PBGS
reaction starts with the binding of the P-side ALA. The
subsequent step in the reaction is the binding of the second
substrate molecule to the A-site. In zinc-dependent PBGS,
the active site metal ion is essential for the binding of A-side
ALA (12). Crystal structures support this scenario (13) (PDB
entry 1e51).
On the basis of structural and biochemical data, we and
others previously postulated a catalytic mechanism for PBGS
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initiated by the formation of Schiff bases between the two
substrate molecules and two conserved lysine residues in the
active site (9, 14, 15). Several studies suggest that the reaction
proceeds with the formation of a C-C bond between C3 of
the A-side ALA and C4 of the P-side ALA (9, 11, 13).
Despite the impressive efforts in studying PBGS and its
multistep mechanism (11), many questions are still open.
No unequivocal picture for the succession of the chemical
transformations involved in the enzyme-catalyzed mechanism
has emerged.
In this study, we have employed six synthesized inhibitors
to probe the active site of PaPBGS using X-ray crystal-
lography. Five of the inhibitors resemble bisubstrate ana-
logues (symmetric dicarboxy, di-ç-keto compounds) with
variation of the central linking moiety. The sixth inhibitor
is a close structural analogue of the substrate ALA (see
Figure 1 for structures).
EXPERIMENTAL PROCEDURES
Construction of Expression Vector pLM_PBGS. The vector
was constructed and kindly provided by L. Stith and E. K.
Jaffe (Fox Chase Cancer Center, Philadelphia, PA). After
insertion (NdeI) and internal removal (BamHI) of restriction
sites via QuikChange mutagenesis, the P. aeruginosa hemB
gene was excised from pGEXhemB (16) using NdeI and
BamHI and ligated into similarly digested pET3a, generating
pLM_PBGS. The integrity of the plasmid construct was
verified by DNA sequencing.
Protein Production and Purification. Freshly transformed
Escherichia coli BL21(ìDE3) cells containing vector pLM_P-
BGS were grown in 500 mL batches of LB medium
containing 100 mg/L ampicillin and supplemented with 0.4%
glucose. An inoculum from a single bacterial colony was
grown at 37 °C and vigorously shaken for 16 h. The cells
were harvested by centrifugation, resuspended in fresh LB
medium, and cooled to 17 °C, and protein production was
induced by adding IPTG to a final concentration of 100 íM.
The cells were further grown at 17 °C overnight and
subsequently harvested by centrifugation.
The bacterial pellet from a total growth of 1 L was
resuspended in lysis buffer [50 mM Tris-HCl (pH 8.0), 100
mM NaCl, 0.05% Triton X-100, and 5 mM MgCl2] contain-
ing a protease inhibitor cocktail (Roche Diagnostics) and
disrupted with a French press (2  20 000 lb/in.2). Cell debris
was removed by centrifugation for 45 min at 100000g. The
resulting supernatant was subjected to a 25% (NH4)2SO4
precipitation at 4 °C overnight. After centrifugation at 4 °C
for 20 min at 5000g, the pellet was resuspended in 50 mM
HEPES-KOH (pH 8.0) and 5 mM MgCl2 (buffer A) and
directly loaded onto a phenyl-Sepharose column (V ) 10
mL) which had been previously equilibrated with 50 mM
HEPES-KOH (pH 8.0), 5 mM MgCl2, and 20% (NH4)2SO4
(buffer B). Unbound protein was removed by washing the
column with 3 column volumes of buffer B. Protein was
eluted with a linear gradient from 20 to 0% (NH4)2SO4 in
buffer A. PBGS-containing fractions were identified UV
spectroscopically and by SDS-PAGE, pooled, and directly
loaded onto a DEAE-Sepharose column (V ) 25 mL) which
had been equilibrated with buffer A. Protein was eluted with
a linear gradient from 0 to 1 M KCl in buffer A. PBGS eluted
with 500 mM KCl from the DEAE column. For further
analysis, the enzyme was dialyzed against 100 mM Tris-
HCl (pH 7.5) and 10 mM MgCl2 and concentrated using
Amicon concentrator devices (MWCO ) 10 000). The yield
of purified P. aeruginosa was approximately 100 mg from
1 L of bacterial culture.
Enzyme ActiVity Assay. The activity of PBGS was deter-
mined using a modified Ehrlich’s test which is based on the
reaction between the product PBG and 4-(dimethylamino)-
benzaldehyde as described previously (16).
Determination of IC50 Values. IC50 values were determined
to approximate the potency of the inhibitors. The assay
FIGURE 1: Reaction catalyzed by PBGS and inhibitors. Only trivial names are given.
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contained a final PBGS concentration of 4 íg/mL and
varying final concentrations of inhibitor [from 125 mM (or
lower due to solubility problems) to 12.5 íM] in a bis-tris-
propane (BTP) buffer [100 mM BTP (pH 8.5) and 10 mM
MgCl2]. Stock solutions of protein, buffer, inhibitor, and
water were mixed and incubated at 37 °C for 30 min. To
start the reaction, substrate was added to a final concentration
of 2 mM in a final volume of 400 íL. The mixture was
incubated for 15 min. The PBGS-catalyzed reaction was then
stopped by adding the reaction mixture (350 íL) to the stop
reagent (350 íL) (25% trichloroacetic acid). After centrifu-
gation (3 min at 5000g), the supernatant (450 íL) was treated
with Ehrlich’s reagent (450 íL) [0.4 g of 4-(dimethylamino)-
benzaldehyde in 10 mL of acetic acid and 10 mL of
perchloric acid]. After 15 min at room temperature, the
amount of product was determined by measuring the absor-
bance at 555 nm ( ) 60 200 M-1 cm-1).
For determination of IC50 values, the data of the dose-
response plot were fitted to eq 1.
where h is a Hill coefficient and accounts for potential
deviations from a simple noncooperative inhibition model
(see Discussion for details) (17).
Crystallization and Structure Determination. Protein solu-
tions containing inhibitors were generated by mixing aliquots
of protein solution [20 mg/mL protein, 100 mM Tris-HCl,
and 10 mM MgCl2 (pH 7.5)] and inhibitor solution (see Table
1 for final concentrations). Crystallization lead conditions
were identified using Crystal Screen, Crystal Screen 2, Low
Ionic Strength Screen, Natrix, and Crystal Screen Cryo sparse
matrix screens (Hampton Research, Aliso Viejo, CA) in 96-
well sitting-drop CrystalClear strip racks (Douglas Instru-
ments) with 100 íL of reservoir solution and drops of 3 íL
of reservoir and 3 íL of protein solution. Thereby produced
initial conditions as well as known crystallization conditions
for wild-type PaPBGS (5) were optimized by the hanging-
drop, vapor-diffusion method with 500 íL of reservoir
solution and drops of 5 íL of protein and 5 íL of reservoir
solution in linbro plates (Hampton Research) (Table 1). Prior
to X-ray data collection, crystals were washed in a cryopro-
tective solution for 5 s and flash-frozen in liquid N2 (Table
1). Data collection was performed under cryogenic conditions
using Cu KR radiation and a Rigaku-MSC R-Axis IV++
image plate or synchrotron radiation (PSF, BESSY, Berlin,
Germany; beamline BL1, ì ) 0.98010 Å) using a MAR
Research CCD detector (Table 2).
The structures of PaPBGS in complex with the inhibitors
were determined by difference Fourier synthesis, using the
refined model of wild-type PaPBGS (PDB entry 1b4k). This
was followed by several rounds of refinement using REF-
MAC5 (18, 19) and ARP/wARP (20) and manual model
building using O (21). Na+, K+, Mg2+, and Cl- and ethylene
glycol oligomers were incorporated to match the electron
density, temperature factors, and coordination sphere (22 and
references cited therein). In obvious cases, two to three
alternate amino acid conformations were modeled. The
quality of the structure was checked using PROCHECK (23)
and WhatIf (24).
Analysis of protein-inhibitor interactions was facilitated
by the use of ligplot (25). Overlays have been created using
lsqkab as a part of the CCP4 suite (18). The overlay of the
PBGSs from different organisms (Figure 4A) was generated
by searching for the best fit for the backbone atoms of the
eight central â-strands of these proteins to the respective
residues of wild-type PaPBGS (PDB entry 1b4k). Figures 3
and 4 were generated using PyMOL (DeLano Scientific LLC,
South San Francisco, CA).
Structural coordinates were deposited in the PDB (Table
2).
RESULTS
Expression and Purification of Recombinant P. aeruginosa
PBGS. P. aeruginosa PBGS was produced and purified from
a new expression system which is under the control of a T7
promoter. The advantage of this system over the previous
one (GST fusion) (16) is the extremely high protein yield
(100 mg of protein per liter of bacterial culture) and the
lack of an affinity tag for purification. Therefore, the
recombinant protein employed in this study most closely
resembles the native enzyme. The obtained protein was
purified to 98% homogeneity.
Inhibition Potency of the Employed Inhibitors. Five
analogues of a bisubstrate were synthesized (26) and tested
in the standard PBGS assay system. Common to all
compounds are the two carboxylate groups and two keto
functions. The only difference between the analogues is the
variation of the central function and consequently the volume
Table 1: Crystallization and Cryo Data
5-OH-LA/
PaPBGS
“amine”/
PaPBGS “ether”/PaPBGS
“sulfoxide”/
PaPBGS
“sulfone”/
PaPBGS
“thioether”/
PaPBGS
protein
solution
10 mg/mL protein,
50 mM Tris-HCl
(pH 7.5),
5 mM MgCl2,
10 mM 5-OH-LA
sodium salt
10 mg/mL protein,
50 mM Tris-HCl
(pH 7.5),
5 mM MgCl2,
1 mM NaCl,
1 mM “amine”
monosodium salt
10 mg/mL protein,
100 mM Tris-HCl
(pH 7.5),
5 mM MgCl2,
5 mM “ether”
10 mg/mL protein,
50 mM Tris-HCl
(pH 7.5),
5 mM MgCl2,
10 mM “sulfoxide”
disodium salt
10 mg/mL protein,
50 mM Tris-HCl
(pH 7.5),
5 mM MgCl2,
10 mM “sulfone”
disodium salt
10 mg/mL protein,
50 mM Tris-HCl
(pH 7.5),
5 mM MgCl2,
10 mM “thioether”
disodium salt
reservoir 9.0% (w/v)
PEG-4000,
180 mM KCl,
9 mM CaCl2,
0.05 mM sodium
cacodylate (pH 6.0),
18.0% (w/v)
PEG-3350,
200 mM LiNO3
12.0% (w/v)
PEG-8000,
340 mM Li2SO4,
20% (v/v) glycerol
18.0% (w/v)
PEG-3350,
220 mM LiCl
31.0% (v/v)
PEG-400,
100 mM
Na-HEPES (pH 7.5),
180 mM MgCl2
17.0% (w/v)
PEG-3350,
120 mM sodium
tartrate
cryoprotective
solution
20% (v/v) PEG-400,
80% reservoir
solution
20% (v/v) PEG-400,
80% reservoir
solution
crystal directly
frozen in its
mother liquor
20% (v/v) PEG-400,
80% reservoir
solution
10% (v/v) PEG-400,
90% reservoir
solution
20% (v/v) PEG-400,
80% reservoir
solution
A
A0
) 1
1 + ( [I]IC50)h (1)
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and polarity of this moiety (Figure 1). It has been shown
previously that the carboxylate group and the ç-keto groups
are essential for recognition by the enzyme (27, 28). In
addition to the bisubstrate analogues, one single-substrate
analogue, 5-hydroxylevulinic acid (5-OH-LA), was employed
(29).
To approximate the potency of the inhibitors, their IC50
values were determined using protein and substrate concen-
trations comparable to those used in earlier studies (9, 14,
30). The data are summarized in Figure 2, and deduced IC50
values are listed in Table 3. “Ether”, “amine”, and “thioether”
are decent inhibitors with IC50 values of <1 mM, whereas
the three others displayed weaker inhibition potency. Data
obtained for “sulfone” and “sulfoxide” were the only ones
that fit eq 1 with a Hill coefficient (h) that deviated
significantly from unity (Table 3).
Crystal Structures of the ActiVe Site of P. aeruginosa
PBGS with the Various Inhibitors. Because of the excellent
crystallization behavior of PaPBGS, we were able to
determine structures with each inhibitor bound. All enzymes
display the same overall fold that has been described for the
wild-type enzyme (5). The loop covering the active site
(“active site flap”) of monomer A is ordered in all structures
except for “sulfoxide”/PaPBGS, while in “sulfone”/PaPBGS,
it displays a hitherto unobserved but ordered conformation.
Table 2: X-ray and Refinement Data
5-OH-LA “amine” “ether” “sulfoxide” “sulfone” “thioether”
structure determination
space group P4212 P4212 P4212 P4212 P4212 P4212
cell dimensions
a (Å) 126.31 126.88 127.54 125.51 125.60 127.20
b (Å) 126.31 126.88 127.54 125.51 125.60 127.20
c (Å) 85.48 86.10 85.79 86.77 86.57 85.85
total no. of reflectionsa 418190 433644 798378 297780 339607 467805
no. of unique reflections 37881 55853 117544 45985 55920 44731
resolution range (Å)b 40.2-2.15
(2.23-2.15)
40.13-1.90
(1.94-1.90)
38.10-1.48
(1.51-1.48)
39.68-2.02
(2.07-2.02)
39.50-1.93
(1.98-1.93)
34.26-2.05
(2.10-2.05)
completeness (%)b 99.2 (99.5) 98.8 (95.2) 96.2 (98.2) 99.8 (99.8) 95.0 (93.4) 97.8 (97.7)
redundancyb 11.0 (9.9) 7.8 (7.0) 6.8 (6.1) 6.5 (6.0) 6.1 (5.5) 10.5 (9.5)
Rmergeb,c 12.6 (45.6) 16.3 (48.3) 8.0 (36.0) 4.1 (22.6) 11.6 (47.9) 12.3 (46.2)
I/óIb 16.7 (4.9) 9.9 (2.0) 19.3 (3.1) 38.0 (4.17) 11.7 (3.46) 14.5 (4.3)
temperature factor (Å2) 22.5 19.2 10.6 17.9 20.3 20.9
refinement
resolution range used
for refinement (Å)d
89.8-2.15 89.8-1.90 90.17-1.48 89.8-2.02 89.8-1.93 89.8-2.05
no. of reflectionsa 35917 52367 107399 43556 47003 41499
no. of non-H protein
atoms/dimer
6020 6349 6841 6395 6180 6273
no. of solvent
molecules/dimer
456 723 968 654 639 659
no. of ions/dimer
Na+ - - - - 2 2
K+ 2 - - - - -
Mg2+ 2 2 2 2 7 2
Cl- 2 - - 1 2 -
average B-factor (Å2) 17.70 18.02 11.31 15.63 19.11 18.43
R-factor (%), Rfree (%)e 15.5, 20.4 15.99, 20.12 14.91, 17.11 14.48, 18.33 15.13, 18.63 14.66, 20.11
Ramachandran plotf (%)
most favored regions 92.6 94.6 94.1 93.4 93.0 93.5
additionally allowed regions 6.8 5.4 5.9 6.6 6.8 6.5
generously allowed regions 0.4 0.0 0.0 0.0 0.0 0.0
rms deviation from ideality
bond lengths (Å) 0.017 0.016 0.008 0.015 0.015 0.016
bond angles (deg)g 1.696 1.525 1.249 1.474 1.469 1.497
estimated overall coordinate
error, based on maximum
likelihood (Å)
0.112 0.089 0.036 0.088 0.085 0.097
beamline home source Bessy, PSF, BL1 Bessy, PSF, BL1 Bessy, PSF, BL1 Bessy, PSF, BL1 home source
PDB entry 2c13 2c14 2c15 2c16 2c18 2c19
a Greater than 1ó. b Value for the highest-resolution shell in parentheses. c Rmerge ) 100(∑h,ijIh,iIhj/∑h,i Ih,i), where summation is over all Ih,i
observations contributing to the Ih reflection intensities. d Fc for a range of 87.71-20.0 Å. e Five percent of the data was omitted from refinement
(42). f Calculated using Procheck (23). g Calculated using Whatif (24).
FIGURE 2: Dose-response plots for the determination of IC50
values. Shown is the dependence of product formation (here shown
as absorbance at 555 nm for the complex of PBG with Ehrlich’s
reagent) on inhibitor concentration: (b) 5-OH-LA, (O) “amine”,
(1) “ether”, (4) “thioether”, (9) “sulfoxide”, and (0) “sulfone”.
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In the case of “sulfone”/PaPBGS, this might be due to the
special binding of the inhibitor (see below) that induces slight
changes (CR atom shifts of D131 and Q138 of approximately
0.8 and 1.0 Å, respectively) in the loop connecting D131 to
D139 lying adjacent to the active site flap. In “sulfoxide”/
PaPBGS, Q138 and H136 exhibit two alternative, shifted
positions potentially contributing to a destabilization of the
active site flap. All residues responsible for coordination of
the inhibitors, including R215 and K229, are nevertheless
well resolved in all structures.
The crystal structure of PaPBGS in complex with 5-OH-
LA is of certain interest, as this inhibitor is the closest
possible structural and chemical mimic of ALA (Figure 1).
Because of this, it is able to perform very similar interactions
with the enzyme, although its is unable to undergo the
condensation reaction. Two molecules of 5-OH-LA are
bound to the A- and P-site. Both are fixed via Schiff bases
to K205 and K260, and their conformation is analogous to
the binding of 5F-LA (Figure 3A) (9). Nevertheless, the
interactions of the moieties in the 5 position of inhibitor
species 5F-LA and 5-OH-LA differ notably. While the two
fluorine atoms of the 5F-LA molecules coordinate a monov-
alent cation that is integrated into a network of hydrophilic
interactions, the hydroxy groups of the A-site 5-OH-LA
inhibitor directly interact with the respective residues (D139
and S175) through H-bonds. Furthermore, the inhibitor in
the P-site is stabilized not only through the Schiff base
fixation to K260 but also via the fixation of the carboxylic
group through interactions with Y324 and S286 and via
hydrophobic interactions between the inhibitors’ apolar part
(C2-C5) and F86, Y202, Y211, F214, and Y283. The A-side
5-OH-LA is fixed via the Schiff base to K205 but also forms
hydrophilic interactions with its carboxylic group with R215,
K229, Q233, and a water molecule and with D139 and S175
(O and Oç) with its hydroxyl group. On the basis of the
similarity between 5-OH-LA and the substrate, we propose
that the complex represents a snapshot of the onset of
catalysis (Figure 5). Recently, the structure of yeast PBGS
in complex with 5-OH-LA was determined. In contrast to
the structure presented here, 5-OH-LA is bound in two
conformations in the yeast PBGS but only to the P-site lysine
residue (31).
The high-resolution structure of “ether”/PaPBGS gives an
ambiguous picture of the inhibitor’s binding (Figure 3B):
The P-side part of “ether” including the ether moiety as well
as C2 and the carboxylic group of the A-side part are nicely
defined by electron density, while the rest of the molecule
(except partly the keto group) is flexible and not resolved in
the electron density. This part was modeled with the most
likely conformation based on conformational constraints. The
second Schiff base in the A-site is not formed according to
the electron density. The conformation of the defined part
in the P-site is identical to the conformation found in 5F-
H-bond with one of these two water molecules.
The structure of “sulfoxide”/PaPBGS is much like those
of “amine”/PaPBGS and “thioether”/PaPBGS except for the
differences in the loop connecting D131 to D139 (Figure
3E). Again, formation of a C-C bond has occurred, and its
conformation and interaction with the surrounding residues
are analogous to those of “amine” and “thioether” except
for the sulfoxide moiety. The amine moiety is a H-bond
donor, while the thioether is apolar. The sulfoxide moiety
on the contrary is bulkier and a H-bond acceptor. In this
structure, the side chains of D131 and D139 are moved
slightly away from the inhibitor compared to those of 5-OH-
LA/PaPBGS and PaPBGS possibly due to this change in
Table 3: IC50 Values for the Employed Inhibitors
inhibitor IC50 (mM) Hill coefficient (h)
5-OH-LA 4.05 1
“ether” 0.963 1
“amine” 0.313 1
“sulfoxide” 38.4 0.64
“sulfone” 9.94 1.61
“thioether” 0.342 1
LA/PaPBGS (9), 5-OH-LA/PaPBGS, and ALA/ScPBGS 
(32) (Figure 4A,B) structures, allowing comparable interac-
tions of both the carboxylic group (hydrophilic) and the 
apolar part (C7-C10, hydrophobic) with the surrounding 
residues. Furthermore, the interactions responsible for the 
recognition of the A-side carboxylic group and the position-
ing of this group are consistent with the 5-OH-LA/PaPBGS 
structure. The C4 keto moiety possibly deploys H-bonds to 
two of the water molecules present in the active site.
The determination of the structures of PaPBGS in complex 
with “amine” and “thioether” revealed additional insights 
(Figure 3C,D). Both inhibitors are covalently linked with 
their C4 and C8 atoms to the amino moieties of K205 and 
K260, respectively. Interestingly, in both cases, the structure 
reveals continuous electron density directly connecting C3 
and C8 of the inhibitors, indicating that a C-C bond has 
been formed. We postulate that initially both keto moieties 
of the inhibitors have been linked to the lysines via Schiff 
bases followed by an aldole addition of C3 of the A-side to 
C8 of the P-side. Consequently, bond formation brings the 
two parts of the inhibitor and thereby the lysine amino groups 
closer together. Nevertheless, no significant rearrangements 
of the surrounding residues are observed when they are 
compared to the 5F-LA/PaPBGS, 5-OH-LA/PaPBGS, and 
ALA/ScPBGS structures (Figure 4A). Instead, the P-side part 
of the inhibitor changes its conformation except the car-
boxylic group which is kept fixed in its position (Figure 
3A,C,D). For the same reasons, the position of the A-side 
carboxylic group is slightly shifted in both structures. 
Thereby, these “upper” parts of the reacted inhibitors 
(comprising C1 to C4 and C8 to C11 in A- and P-side, 
respectively) serve as a model for an intermediate, in which 
the C-C bond formation has occurred. This can be seen in 
an overlay of these inhibitors with this respective intermedi-
ate that had been modeled in the structure of HsPBGS mutant 
F12L (7) [intermediate 1, Figure 5/IV and Figure 4C]. This 
comparison underscores the relevance of these reacted 
inhibitors as mimics of reaction intermediates.
The reacted inhibitors are stabilized by hydrophobic 
interactions with M177, A204, Y211, F214, Y283, V285, 
and S286. As found for all bound compounds so far (Figure 
4A-C), the P-side carboxylic groups of “amine” and 
“thioether” are fixed through H-bonds to S286 (Oç and N) 
and Y324. Their A-side carboxylic groups interact with 
R215, K229, Q233, and a water molecule that is part of a 
hydrophilic network at the A-site, which also includes D131, 
D139, S175, and two additional water molecules. In contrast 
to the hydrophobic thioether moiety of “thioether”, the 
secondary amino moiety of “amine” forms an additional
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the polarity. These changes are accompanied by the emer-
gence of a second conformation for residues 136-138 and
a disordered active site flap. The remainder of the active
site nevertheless is unaffected.
Among the diketo inhibitors, “sulfone” exhibits the most
unexpected mode of binding, unmatched by any other PBGS
structure so far (Figure 3F). It is covalently fixed only with
one of its keto groups via a Schiff base to K260 in the P-site.
As in “ether”/PaPBGS, the second Schiff base is not formed,
and coincidentally, the conformation of its P-site part
resembles the P-sites of 5F-LA/PaPBGS, 5-OH-LA/PaP-
BGS, and ALA/ScPBGS (Figure 4B). Furthermore, the
A-side part of “sulfone” is clearly defined by electron density.
The respective carboxylic moiety lies in the expected position
but with an orientation tilted by 90° highlighting the degree
of structural flexibility in this part of the active center. The
formation of the second Schiff base has not yet occurred;
instead, the keto group oxygen and one of the sulfonyl
oxygen atoms are within H-bonding distance of N of K205.
This unexpected conformation is very likely a precondition
for the binding of a metal ion in the active site, coordinated
by D131, D139, D176, and three water molecules (Figures
3F and 4D). Several indications are consistent with the need
for a magnesium ion: an octahedral coordination sphere, the
distances of 2.02-2.17 Å between the coordinating oxygen
atoms and the metal ion (22 and references cited therein),
and the amount of electron density (calcium, manganese, or
zinc ions would fit the electron density at only low
occupancies). Furthermore, magnesium is the only divalent
cation present in significant amounts in the purification and
crystallization solutions. The inhibitor chelates the supposed
magnesium ion indirectly. Two of the magnesium ion
coordinating water molecules are within H-bonding distance
of the carboxylic moiety of the A-side part of the inhibitor.
The third water molecule is part of a hydrophilic network
comprising D127, S175, the sulfonyl moiety of the inhibitor,
and another water molecule. Additionally, circular-shaped
electron density was found adjacent to the magnesium
binding site that could not be sufficiently explained by a
water molecule. Instead, it was interpreted as a chloride ion
fitting well the electron density. It exhibits a relatively short
H-bond to one of the magnesium ion coordinating residues
(2.86 Å) as well as two long H-bonds to the backbone amide
of M177 (3.22 Å) and the side chain amide nitrogen of Q233
(3.29 Å). This chloride ion completes a network of H-bond
donors and acceptors. This is the first time that either a
magnesium or a chloride ion has been found in the active
site of any PBGS structure.
DISCUSSION
Kinetic Measurements
“Amine”, “ether”, and “thioether” are relatively good
inhibitors compared to other compounds assessed previously
(9), while 5-OH-LA, “sulfone”, and especially “sulfoxide”
are weaker inhibitors. Interestingly, the inhibition data
obtained for “sulfoxide” and “sulfone” could only be fitted
to the dose-response equation if a Hill coefficient (h) was
introduced. Different events can account for deviations
leading to the introduction of Hill coefficients: nonideal
behavior of the inhibitor, cooperativity in the binding process
due to the multimeric character of the protein, alteration of
the multimeric state of the enzyme, more then one binding
site per monomer for the inhibitor, etc. (17). At this point,
we cannot state the reason for these deviations. One might
be the alteration of multimeric states of the protein. In this
regard, recent findings describe the existence of freely
equilibrating alternate PBGS quaternary isoforms, called
morpheeins for mutants of the human PBGS (7, 33, 34). It
has been proposed that the wild-type enzyme exists as an
equilibrium of octameric and hexameric forms, the latter of
which has been shown to have decreased affinity for the
substrate due to the loss of interaction between the active
site flap and the carboxyl moieties of the A-side ALA (34).
If this concept holds true for other wild-type PBGSs,
inhibitor binding might alter this equilibrium and there-
fore account for the observed deviations of the Hill coef-
ficient from 1.0. This might then lead to different binding
constants for the inhibitors for the different oligomeric
states.
Conformational Differences between PBGSs in the
Inhibitor Complex Structures
The conformational differences among the six PaPBGS
structures are restricted to the loop connecting D131 with
FIGURE 3: Structures of the six inhibitors bound to PaPBGS with labels according to PaPBGS numbering. All nitrogen, oxygen, and sulfur
atoms are colored blue, red, and yellow, respectively, according to the CPK color convention. Carbon atoms of K205 and K260 are colored
with the same color as the respective inhibitor carbon atoms. (A) 5-OH-LA (orange) bound to K205 (A-site) and K260 (P-site) through
Schiff base linkages. The blue mesh represents the electron density at level of 1.0ó. Surrounding residues are colored gray, and water
molecules are depicted as red spheres. (B) “Ether” (yellow) bound to K260 (P-site) via a Schiff base. Clearly no intramolecular bond was
formed. The blue mesh represents the electron density at a level of 1.0ó. C3-C5 of the inhibitor molecule are not defined by electron
density and are modeled as the most likely conformation due to conformational restraints. Surrounding residues are colored in gray, and
water molecules are depicted as red spheres. D139 exhibits two alternative conformations. (C) “Amine” (green) bound to K205 (A-site) and
K260 (P-site) via a Schiff base and a single bond, respectively. The blue mesh represents the electron density at a level of 1.0ó. The aldole
reaction between C3 and C8 of the inhibitor has created a new bond as shown by the continuous electron density between these two atoms.
Surrounding residues are colored gray, and water molecules are depicted as red spheres. D139 exhibits two alternative conformations. (D)
“Thioether” (blue) bound to K205 (A-site) and K260 (P-site) via a Schiff base and a single bond, respectively. The green mesh represents
the electron density at a level of 1.0ó. The aldole reaction between C3 and C8 of the inhibitor has created a new bond as shown by the
continuous electron density between these two atoms. Surrounding residues are colored gray, and water molecules are depicted as red
spheres. (E) “Sulfoxide” (purple) bound to K205 (A-site) and K260 (P-site) via a Schiff base and a single bond, respectively. The blue
mesh represents the electron density at a level of 1.0ó. The aldole reaction between C3 and C8 of the inhibitor has created a new bond as
shown by the continuous electron density between these two atoms. Surrounding residues are colored gray, and water molecules are depicted
as red spheres. D131 exhibits two alternative conformations. (F) “Sulfone” (salmon) bound to K260 (P-site) via a Schiff base. Clearly no
intramolecular bond was formed. The blue mesh represents the electron density at a level of 1.0ó. Surrounding residues are colored gray,
and water molecules are depicted as red spheres. D131 exhibits two alternative conformations. A magnesium ion (light purple) and a
chloride ion (light yellow) are bound to the active site.
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FIGURE 4: Overlays and a close-up of the magnesium binding site in “sulfone”/PaPBGS. (A) Overlay of the residues lining the active centers of 5-OH-LA/PaPBGS (orange), “ether”/PaPBGS
(yellow), “amine”/PaPBGS (green), “sulfone”/PaPBGS (blue), ALA/ScPBGS (gray) (32), DOSA/EcPBGS (pink) (28), intermediate 1/HsPBGS mutant F12L (cyan) (7), and intermediate 2/ScPBGS
(deep olive) (13), with the numbering from PaPBGS, and alternative residues in EcPBGS, ScPBGS, and HsPBGS in italics. The A- and P-site lysines with their bound respective compounds are
colored black. Most of the active site residues closely align, while the members of the two flexible loops corresponding to D127, D131, D139, and K229 are less fixed in their positions.
Equivalents of D131, D139, and K229 are mutated in the zinc-binding enzymes. In the HsPBGS mutant F12L, equivalents of Q233, D131, D139, and K229 are undetectable due to disordering
of this part of the active site in this mutant. When a magnesium ion binds in this region in “sulfone”/PaPBGS, D131 and D139 are significantly shifted compared to those of the other PaPBGS
structures. The positioning of the carboxylic group of all compounds in the P-site seems to be very rigid, while there is diversity in the positioning of the second carboxylic group in the A-site.
(B) Overlay of 5-OH-LA/PaPBGS (orange), “ether”/PaPBGS (yellow), “sulfone”/PaPBGS (blue), ALA/ScPBGS (gray) (32), and DOSA/EcPBGS (purple) (28). The conformation of substratelike
(unreacted) molecules seems to be structurally conserved in the P-site. The amino moiety of the A-site lysine in DOSA/EcPBGS is forced to the left to accommodate the formation of a second
Schiff base; the wounded conformation of DOSA is therefore not suitable for C-C bond formation. (C) Overlay of “amine”/PaPBGS (green), intermediate 1/HsPBGS mutant F12L (cyan) (7),
and intermediate 2/ScPBGS (deep olive) (13). “Amine” is a good mimic of intermediate 1. (D) Magnified view of the magnesium binding site in the active center of “sulfone”/PaPBGS. The
electron density at a level of 1.0ó describes the ion and its octahedral coordination sphere formed of D131, D139, D176, and three water molecules that interact with “sulfone” and the chloride
ion through H-bonds.
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D139 and the neighboring active site flap. The remainder of
the enzyme and, especially, the rest of the active site appear
to be remarkably rigid and unaffected by the binding of
different compounds. This observation can be expanded even
to structures of PBGSs from other sources with or without
different substances bound (Figure 4A). Therefore, the
necessary flexibility of the active site is achieved by residues
belonging to these two loops. Variations range from the
binding of different numbers of water molecules in this
region to the presence of a magnesium and chloride ion in
the case of “sulfone”/PaPBGS (see below). The flexibility
of the loops is also reflected by the temperature factors of
the corresponding residues lying well above the average for
all structures.
A Magnesium Ion in the ActiVe Site
The binding of a magnesium ion in the active sites of
PBGSs lacking the active site zinc binding site has been a
continuous matter of discussion. On the basis of kinetic and
NMR data, the binding of a magnesium ion in the active
site of zinc-free PBGSs had been postulated (35, 36), but so
far, all structures of exclusively magnesium binding PBGSs
(5, 6, 9, 10) showed only a magnesium ion bound to an
allosteric binding site distant from the active site. Therefore,
the structure of the “sulfone”/PaPBGS complex is the first
structural hint that a magnesium ion can truly be stabilized
within the active site (Figure 4D). Nevertheless, the interac-
tions stabilizing the magnesium ion in “sulfone”/PaPBGS
are partly artificial due to the artificial nature of the bound
inhibitor. This finding should therefore not be overrated, but
it revives the idea of an intermediary bound magnesium ion
participating in catalysis of zinc-free PBGSs.
Catalytic Mechanism of PaPBGS
The comparison of the six different structures of inhibitor/
PaPBGS complexes together with recently determined
structures now allows us to describe the catalyzed mechanism
in more detail.
(I) Binding of P-Site ALA. At first, a stable Schiff base is
formed between the substrate molecule’s keto moiety and
the amino group of the P-site lysine (K260), as proven by
several crystal structures and Schiff base trapping studies
(Figures 4B and 5, step I) (4, 5, 12, 15, 37-39).
(II) Binding of A-Site ALA. In a similar event, the second
substrate molecule is bound to the second lysine in the A-site
(K205); thereby, the more flexible parts of the active site
(D131, D139, R215, and K229) are stabilized by several
defined interactions. The active site is shielded from the
surrounding medium by the ordering of the active site flap.
5-OH-LA/PaPBGS and 5F-LA/PaPBGS (9) resemble this
state prior to the onset of catalysis (Figures 3A and 5,
step II).
(III) Enamine Formation. In vivo, the second Schiff base
formation is transient and followed by the formation of an
enamine at the A-site as a prelude to the next step.
(IV) Aldole Addition (formation of the C-C bond). The
C-C bond between C3 of the A-site ALA and the P-site
ALA is formed by an aldole addition (Figure 5, step IV).
The formation of the A-site Schiff base and the enamine as
activation seems to be a prerequisite for this reaction step.
FIGURE 5: Proposed catalytic mechanism of PBGS from P. aeruginosa. The steps in the condensation of A- and P-side ALA to form PBG
are indicated: (I) binding of P-side ALA, (II) binding of A-side ALA, (III) abstraction of H+ from C3 of A-side ALA, yielding the A-site
enamine, (IV) aldole addition forming the C-C bond between A- and P-side ALA, (V) Schiff base exchange producing a C-N bond
between A- and P-side ALA, (VI) transfer of H+ to Lys260, (VII) trans elimination of P-site lysine, and (VIII) abstraction of the pro-R H+
from C5 of P-side ALA, aromatization, and release of PBG.
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C-C bond has occurred which is in contrast to complexes
in which the second A-site Schiff base is established
(“amine”/PaPBGS, “thioether”/PaPBGS, and “sulfoxide”/
PaPBGS). These inhibitor structures thereby support the
interpretation of electron density found in the partly disor-
dered active site of HsPBGS that was modeled as this
respective intermediate 1 (Figure 5) (7). Why does formation
of the C-N bond not occur first? Here the comparison
among “amine”/PaPBGS, “thioether”/PaPBGS, “sulfoxide”/
PaPBGS, and DOSA/EcPBGS (Figure 4B,C) (14) helps to
explain that formation of the C-C bond can only occur when
the compounds possess enough conformational flexibility.
This allows the nucleophile (the A-side C3 atom) to attack
the electrophile (P-side C4 atom, i.e., C8 atom of the
inhibitors) along the Burgi-Dunitz angle. This is most likely
the case for the two separate ALA molecules, prior to
formation of the C-N bond.
(V) Schiff Base Exchange (formation of the C-N bond).
Following the aldole addition, the C-N bond is formed
through an attack of the P-side substrate amino moiety on
the A-site Schiff base (Figure 5, step V), leading to a Schiff
base exchange that sets the A-site lysine free. The intermedi-
ate formed this way exactly resembles the intermediate
2/ScPBGS (Figure 4C) and intermediate 2/HsPBGS (13, 40)
complexes and was also found in a structure of PaPBGS
(unpublished results). The existence of such protein inter-
mediate complexes that are even suitable for crystallization
indicates that this state is relatively stable (or metastable).
This relative stability might be the explanation for the slow
conversion of this intermediate into the product through the
lysis of the remaining single bond linking the intermediate
to the P-site lysine (Figure 5, step VII). It has been suggested
that substrate binding in a neighboring active site of the
PBGS multimer triggers a conformational change that
facilitates this lysis (11). The “amine”, “thioether”, and
“sulfoxide” structures clearly support the assumption of
stabilization of closed ring structures by the protein (Figure
3C-E).
(VI) Protonation of P-site lysine and (VII) trans elimina-
tion of P-site lysine might thereby be the rate-limiting step
of catalysis causing the PBGSs to be slow enzymes with
kcat values in the range of 1 s-1 and a kcat/Km of 10 s-1 M-1.
(VIII) Abstraction of the pro-R H+ from C5 of P-side ALA
(41), aromatization, and release of PBG after lysis of the
connecting bond between intermediate 2 and the P-site lysine
(Figure 5, step VIII) are the last steps of the catalytic process
prior to product release.
This last step, the formation of the aromatic ring structure,
provides the driving force for the whole reaction.
Why do 5F-LA and 5-OH-LA not form the C-C bond?
Obviously, they are not able to form an intermediate with a
ring structure that is stabilized by the enzyme, and conse-
quently, the reaction is stalled prior to formation of the C-C
bond.
Conclusion and Outlook
The new crystal structures of PaPBGS in complex with
several inhibitors presented here allowed us to confirm the
catalytic mechanism of PaPBGS proposed in an earlier study
(9). Comparison with the findings of Erskine et al. (13) and
Breinig et al. (7) and the mechanisms proposed by these
groups leads to the conclusion that substrate binding and
activation through two Schiff bases, the initial C-C bond
formation, and the stabilization of a ring structure intermedi-
ate are fundamentals of PBGS catalysis.
Nevertheless, the function of metal ions in the catalytic
process remains an open question. The participation of the
zinc ion at the active site in zinc-binding enzymes has been
postulated (4, 11). The “sulfone”/PaPBGS structure in which
a magnesium ion is bound to the active site sheds new light
on the direct involvement of magnesium ions in the mech-
anism for exclusively magnesium binding PBGSs. To tackle
this question, new kinetic and crystallization experiments are
underway.
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